Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001209191-23-033823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-05-31 | APVO | Kwon SoYoung | SVP, GC, BD, Corp Affairs | M - OptEx | — | +1,834 | 7,333 | +33% | — |
| D | 2023-06-02 | 2023-05-31 | APVO | Kwon SoYoung | SVP, GC, BD, Corp Affairs | M - OptEx | $0.00 | -1,834 | 1,833 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-31 | M | A | 1,834 | — | 7,333 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-05-31 | M | D | 1,834 | $0.00 | 1,833 | D | — · — to — | 1,834 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On June 1, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022. |